ES2724232T3 - Procedimientos de detección de células tumorales circulantes positivas para 5T4 y procedimientos de diagnóstico de cáncer positivo para 5T4 en un sujeto mamífero - Google Patents
Procedimientos de detección de células tumorales circulantes positivas para 5T4 y procedimientos de diagnóstico de cáncer positivo para 5T4 en un sujeto mamífero Download PDFInfo
- Publication number
- ES2724232T3 ES2724232T3 ES13708526T ES13708526T ES2724232T3 ES 2724232 T3 ES2724232 T3 ES 2724232T3 ES 13708526 T ES13708526 T ES 13708526T ES 13708526 T ES13708526 T ES 13708526T ES 2724232 T3 ES2724232 T3 ES 2724232T3
- Authority
- ES
- Spain
- Prior art keywords
- marker
- cells
- blood sample
- positive
- circulating tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
- G01N33/5759—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds localised on the membrane of tumour or cancer cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70589—CD45
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Sampling And Sample Adjustment (AREA)
- Oncology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261590066P | 2012-01-24 | 2012-01-24 | |
| US201361753665P | 2013-01-17 | 2013-01-17 | |
| PCT/IB2013/050547 WO2013111054A1 (en) | 2012-01-24 | 2013-01-22 | Methods for detecting 5t4-positive circulating tumor cells and methods of diagnosis of 5t4-positive cancer in a mammalian subject |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2724232T3 true ES2724232T3 (es) | 2019-09-09 |
Family
ID=47844410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES13708526T Active ES2724232T3 (es) | 2012-01-24 | 2013-01-22 | Procedimientos de detección de células tumorales circulantes positivas para 5T4 y procedimientos de diagnóstico de cáncer positivo para 5T4 en un sujeto mamífero |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10254286B2 (2) |
| EP (1) | EP2807485B1 (2) |
| JP (1) | JP6254951B2 (2) |
| KR (1) | KR101716555B1 (2) |
| CN (1) | CN104094116B (2) |
| AU (2) | AU2013213301A1 (2) |
| BR (1) | BR112014018192A8 (2) |
| CA (1) | CA2861437C (2) |
| ES (1) | ES2724232T3 (2) |
| IL (1) | IL233543B (2) |
| IN (1) | IN2014DN07019A (2) |
| MX (1) | MX361058B (2) |
| RU (1) | RU2646498C2 (2) |
| WO (1) | WO2013111054A1 (2) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2803804B2 (ja) | 1992-08-21 | 1998-09-24 | 株式会社長澤製作所 | ボタン錠 |
| EP3045918B1 (en) | 2009-10-21 | 2017-12-06 | The Scripps Research Institute | Method of using non-rare cells to detect rare cells |
| US8956859B1 (en) | 2010-08-13 | 2015-02-17 | Aviex Technologies Llc | Compositions and methods for determining successful immunization by one or more vaccines |
| EA201691352A1 (ru) * | 2013-12-30 | 2016-11-30 | Дзе Скриппс Рисерч Инститьют | Диагностика рака легкого с помощью циркулирующих опухолевых клеток |
| EA201691496A1 (ru) | 2014-01-27 | 2016-12-30 | Эпик Сайенсиз, Инк. | Диагностика биомаркеров рака предстательной железы с помощью циркулирующих опухолевых клеток |
| EA201691682A1 (ru) * | 2014-02-21 | 2017-02-28 | Эпик Сайенсиз, Инк. | Способы анализирования редких циркулирующих в крови клеток |
| WO2015155345A1 (en) * | 2014-04-11 | 2015-10-15 | Medimmune Limited | Antibodies and antibody-drug conjugates |
| EA201692223A1 (ru) * | 2014-05-09 | 2017-04-28 | Дзе Скриппс Рисерч Инститьют | Композиции и способы жидкостной биопсии меланомы |
| CA2959072C (en) * | 2014-08-25 | 2025-12-09 | Creatv Microtech, Inc. | Use of circulating cell biomarkers in the blood for detection and diagnosis of diseases and methods of isolating them |
| CN113552350B (zh) * | 2015-04-21 | 2024-10-11 | 基因泰克公司 | 用于前列腺癌分析的组合物和方法 |
| KR102771841B1 (ko) * | 2015-11-06 | 2025-02-24 | 벤타나 메디컬 시스템즈, 인코포레이티드 | 대표 진단법 |
| KR20170099738A (ko) | 2016-02-23 | 2017-09-01 | 노을 주식회사 | 접촉식 염색 패치 및 그 제조 방법 |
| KR102406596B1 (ko) * | 2016-02-23 | 2022-06-10 | 노을 주식회사 | 패치를 이용하는 ctc 진단 방법 및 장치 |
| KR102478639B1 (ko) | 2016-02-23 | 2022-12-19 | 노을 주식회사 | 표지 물질을 저장하는 패치, 이를 이용하는 조직 진단 방법 및 장치 |
| US10371610B2 (en) | 2016-02-23 | 2019-08-06 | Noul Co., Ltd. | Contact-type patch, staining method using the same, and manufacturing method thereof |
| KR102045069B1 (ko) * | 2016-02-23 | 2019-11-15 | 노을 주식회사 | 패치를 이용하는 ctc 진단 방법 및 장치 |
| SG11201909218RA (en) | 2017-04-03 | 2019-11-28 | Hoffmann La Roche | Antibodies binding to steap-1 |
| EP3646010A4 (en) * | 2017-06-27 | 2020-11-11 | Qcdx, Llc | QUANTITATIVE LIQUID BIOPSY DIAGNOSTIC SYSTEM AND METHOD |
| CN107918013A (zh) * | 2017-09-25 | 2018-04-17 | 浙江天科高新技术发展有限公司 | 化学发光酶免测定循环肿瘤细胞中K‑Ras蛋白的方法及试剂盒 |
| JP7678424B2 (ja) | 2018-05-10 | 2025-05-16 | 学校法人順天堂 | 画像解析方法、装置、コンピュータプログラム、及び深層学習アルゴリズムの生成方法 |
| WO2020086882A1 (en) * | 2018-10-24 | 2020-04-30 | Northwestern University | Tumor cell aggregation inhibitors' for treating cancer |
| JP7381003B2 (ja) * | 2019-04-26 | 2023-11-15 | 学校法人順天堂 | 疾患解析を支援する方法、装置、及びコンピュータプログラム、並びにコンピュータアルゴリズムを訓練する方法、装置、及びプログラム |
| EP4445141A1 (en) | 2021-12-07 | 2024-10-16 | Epic Sciences, Inc. | Enhanced characterization of breast cancer |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4391904A (en) | 1979-12-26 | 1983-07-05 | Syva Company | Test strip kits in immunoassays and compositions therein |
| US5869053A (en) | 1988-03-04 | 1999-02-09 | Cancer Research Campaign Technology, Ltd. | 5T4 antigen from human trophoblasts |
| WO1989007947A1 (en) | 1988-03-04 | 1989-09-08 | Cancer Research Campaign Technology Limited | Improvements relating to antigens |
| EP1717248A1 (en) | 1997-06-04 | 2006-11-02 | Oxford Biomedica (UK) Limited | Tumor targeted vector |
| JP2003515323A (ja) | 1999-11-18 | 2003-05-07 | オックスフォード バイオメディカ（ユーケイ）リミテッド | 抗 体 |
| GB0126378D0 (en) | 2001-11-02 | 2002-01-02 | Oxford Biomedica Ltd | Antigen |
| US7305112B2 (en) | 2002-10-15 | 2007-12-04 | The Scripps Research Institute | Method of converting rare cell scanner image coordinates to microscope coordinates using reticle marks on a sample media |
| PE20100251A1 (es) * | 2004-09-10 | 2010-04-10 | Wyeth Corp | Anticuerpos anti-5t4 humanizados y conjugados anticuerpo anti-5t4/calicheamicina |
| EP1984030B1 (en) | 2006-01-30 | 2013-05-08 | The Scripps Research Institute | Methods for detection of circulating tumor cells and methods of diagnosis of cancer in a mammalian subject |
| MY148763A (en) | 2006-03-10 | 2013-05-31 | Wyeth Corp | Anti-5t4 antibodies and uses thereof |
| US20100233694A1 (en) | 2007-04-16 | 2010-09-16 | On-O-ity, Inc | Devices and methods for diagnosing, prognosing, or theranosing a condition by enriching rare cells |
| GB0822836D0 (en) * | 2008-12-15 | 2009-01-21 | Oxford Biomedica Ltd | Method |
| AU2010229924B2 (en) | 2009-03-24 | 2016-07-21 | Plus Therapeutics Inc. | Devices and methods of cell capture and analysis |
| ES2405605T3 (es) | 2009-03-27 | 2013-05-31 | Wyeth Llc | Células iniciadoras de tumores y procedimientos de uso de las mismas |
| JP2013504064A (ja) | 2009-09-03 | 2013-02-04 | ザ スクリプス リサーチ インスティチュート | 循環腫瘍細胞を分類する方法 |
| EP3045918B1 (en) | 2009-10-21 | 2017-12-06 | The Scripps Research Institute | Method of using non-rare cells to detect rare cells |
| WO2011127219A1 (en) * | 2010-04-06 | 2011-10-13 | Caris Life Sciences Luxembourg Holdings | Circulating biomarkers for disease |
| EP2591363B1 (en) | 2010-07-07 | 2017-09-20 | The Regents Of The University Of Michigan | Diagnosis and treatment of breast cancer |
| DK2694111T3 (en) | 2011-04-01 | 2016-10-10 | Wyeth Llc | Antibody pharmaceutical conjugates |
-
2013
- 2013-01-22 AU AU2013213301A patent/AU2013213301A1/en not_active Abandoned
- 2013-01-22 BR BR112014018192A patent/BR112014018192A8/pt not_active Application Discontinuation
- 2013-01-22 MX MX2014008928A patent/MX361058B/es active IP Right Grant
- 2013-01-22 JP JP2014553836A patent/JP6254951B2/ja not_active Expired - Fee Related
- 2013-01-22 CA CA2861437A patent/CA2861437C/en not_active Expired - Fee Related
- 2013-01-22 KR KR1020147020394A patent/KR101716555B1/ko not_active Expired - Fee Related
- 2013-01-22 IN IN7019DEN2014 patent/IN2014DN07019A/en unknown
- 2013-01-22 CN CN201380006333.9A patent/CN104094116B/zh not_active Expired - Fee Related
- 2013-01-22 US US14/374,083 patent/US10254286B2/en not_active Expired - Fee Related
- 2013-01-22 EP EP13708526.2A patent/EP2807485B1/en active Active
- 2013-01-22 ES ES13708526T patent/ES2724232T3/es active Active
- 2013-01-22 RU RU2014127474A patent/RU2646498C2/ru active
- 2013-01-22 WO PCT/IB2013/050547 patent/WO2013111054A1/en not_active Ceased
-
2014
- 2014-07-07 IL IL233543A patent/IL233543B/en active IP Right Grant
-
2018
- 2018-08-24 AU AU2018220154A patent/AU2018220154A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| IL233543B (en) | 2018-02-28 |
| WO2013111054A1 (en) | 2013-08-01 |
| MX2014008928A (es) | 2014-10-24 |
| RU2646498C2 (ru) | 2018-03-05 |
| US20150017661A1 (en) | 2015-01-15 |
| CN104094116B (zh) | 2017-05-31 |
| KR101716555B1 (ko) | 2017-03-14 |
| CA2861437A1 (en) | 2013-08-01 |
| IL233543A0 (en) | 2014-08-31 |
| CN104094116A (zh) | 2014-10-08 |
| RU2014127474A (ru) | 2016-03-20 |
| IN2014DN07019A (2) | 2015-04-10 |
| MX361058B (es) | 2018-11-23 |
| AU2013213301A1 (en) | 2014-07-17 |
| BR112014018192A8 (pt) | 2021-03-02 |
| JP2015507190A (ja) | 2015-03-05 |
| CA2861437C (en) | 2018-08-21 |
| JP6254951B2 (ja) | 2017-12-27 |
| KR20140100580A (ko) | 2014-08-14 |
| HK1202923A1 (en) | 2015-10-09 |
| AU2018220154A1 (en) | 2018-09-13 |
| EP2807485A1 (en) | 2014-12-03 |
| US10254286B2 (en) | 2019-04-09 |
| EP2807485B1 (en) | 2019-03-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2724232T3 (es) | Procedimientos de detección de células tumorales circulantes positivas para 5T4 y procedimientos de diagnóstico de cáncer positivo para 5T4 en un sujeto mamífero | |
| Marrinucci et al. | Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers | |
| ES2661735T3 (es) | Método para usar células no raras para detectar células raras | |
| ES2420834T3 (es) | Métodos de detección de células tumorales circulantes y métodos de diagnóstico del cáncer en un sujeto mamífero | |
| ES2397971T3 (es) | Ensayo de células tumorales circulantes | |
| KR101604649B1 (ko) | 혈액 내 순환 흑색종 세포의 자동화된 계산 및 특징화 | |
| Marrinucci et al. | Circulating tumor cells from well-differentiated lung adenocarcinoma retain cytomorphologic features of primary tumor type | |
| US10823736B2 (en) | Method of assessing disease condition of cancer | |
| MX2014006884A (es) | Aparato, sistema y metodo para identificar celulas tumorales circulantes. | |
| WO2000026666A2 (en) | Multiple marker characterization of single cells | |
| CN101606060A (zh) | 细胞图像的归类方法 | |
| US20180267046A1 (en) | Methods for diagnosing and treating cancer | |
| Yin et al. | Cytokeratin 20 and Ki-67 to distinguish carcinoma in situ from flat non-neoplastic urothelium | |
| JP6936231B2 (ja) | 転移性去勢抵抗性前立腺癌（ｍＣＲＰＣ）患者における治療選択のためのバイオマーカーとしてのアンドロゲン受容体バリアント７ | |
| ES2939298T3 (es) | Combinación de marcadores para el diagnóstico del cáncer | |
| RU2571821C2 (ru) | Способ выявления циркулирующих опухолевых клеток, микроэмбол и апоптотических телец в крови больных раком легкого человека | |
| US20250208138A1 (en) | Method of isolating and analyzing circulating tumor cells | |
| ES2356738T3 (es) | Células tumorales circulantes (ctc): evaluación temprana del tiempo de evolución, de la supervivencia y la respuesta a la terapia en pacientes con cáncer metastásico. | |
| HK1202923B (en) | Methods for detecting 5t4-positive circulating tumor cells and methods of diagnosis of 5t4-positive cancer in a mammalian subject | |
| Cheema | Pancreatic Tumor Cell Capture via Dendrimer-Mediated Multivalent Binding and Antibody Cocktail | |
| JP2024512415A (ja) | 小細胞肺がんおよび他の神経内分泌がんを処置するための方法 | |
| WO2025137394A1 (en) | Using extracellular vesicles to assess treatment efficacy of antibody-drug conjugate (adc) therapies | |
| Smerage et al. | SECTION II: MOLECULAR AND CELLULAR MARKERS OF PROGNOSIS |